| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| anifrolumab ema | 0.46 | 0.7 | 970 | 45 | 15 |
| anifrolumab | 0.41 | 0.5 | 4552 | 56 | 11 |
| ema | 0.05 | 0.5 | 1029 | 33 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| anifrolumab ema | 0.09 | 0.5 | 7994 | 100 |
| anifrolumab epar | 0.79 | 0.8 | 7514 | 8 |
| anifrolumab approval | 0.06 | 0.6 | 3674 | 90 |
| anifrolumab australia | 1.6 | 0.8 | 873 | 27 |
| anifrolumab astrazeneca | 1.68 | 0.6 | 8617 | 29 |
| anifrolumab acr | 1.94 | 0.7 | 2044 | 45 |
| anifrolumab mechanism of action | 0.83 | 1 | 2887 | 64 |
| anifrolumab aifa | 1.75 | 0.7 | 3738 | 54 |
| anifrolumab amm | 0.85 | 0.1 | 6141 | 43 |
| anifrolumab ansm | 0.3 | 0.8 | 8144 | 15 |
| anifrolumab aemps | 1.61 | 0.8 | 8765 | 1 |
| anifrolumab atc code | 1.06 | 1 | 3653 | 12 |
| anifrolumab approval history | 0.07 | 0.9 | 6269 | 6 |
| anifrolumab antagonizes which target molecule | 1.08 | 0.4 | 1843 | 44 |
